antiviral news

Press Releases in the global landscape
Sep 28, 2022
Ildong applies for changing the IND application for Covid-19 treatment
In a public notice Tuesday, Ildong said it had applied to the Ministry of Food and Drug Safety to approve the change in phase 2/3 clinical trial of an investigational new drug (IND) S-217622.
Read More
Sep 27, 2022
Paxlovid: Medical professionals eager to see criteria expanded
Is it time to expand access to Paxlovid, the treatment that reduces symptoms, risk of hospitalization and risk of death from COVID-19?
Read More
Sep 27, 2022
Japan's Shionogi says COVID pill reaches endpoint in Phase III trial
Japan's Shionogi & Co Ltd said on Wednesday its oral treatment for COVID-19 demonstrated a significant reduction in symptoms compared to a placebo in a Phase III trial in Asia.
Read More